Cargando…
Thyroid‐stimulating hormone is an independent risk factor of non‐alcoholic fatty liver disease
BACKGROUND AND AIM: Hypothyroidism might play a crucial role in the pathogenesis of non‐alcoholic fatty liver disease (NAFLD). The association of subclinical hypothyroidism with NAFLD has been inconsistent. The relationship of NAFLD with thyroid function parameters and subclinical hypothyroidism was...
Autores principales: | Tahara, Kazuki, Akahane, Takemi, Namisaki, Tadashi, Moriya, Kei, Kawaratani, Hideto, Kaji, Kosuke, Takaya, Hiroaki, Sawada, Yasuhiko, Shimozato, Naotaka, Sato, Shinya, Saikawa, Soichiro, Nakanishi, Keisuke, Kubo, Takuya, Fujinaga, Yukihisa, Furukawa, Masanori, Kitagawa, Koh, Ozutsumi, Takahiro, Tsuji, Yuuki, Kaya, Daisuke, Ogawa, Hiroyuki, Takagi, Hirotetsu, Ishida, Koji, Mitoro, Akira, Yoshiji, Hitoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273701/ https://www.ncbi.nlm.nih.gov/pubmed/32514444 http://dx.doi.org/10.1002/jgh3.12264 |
Ejemplares similares
-
Chronic Alcohol Consumption is Inversely Associated with Insulin Resistance and Fatty Liver in Japanese Males
por: Akahane, Takemi, et al.
Publicado: (2020) -
Association between Non-Alcoholic Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study
por: Akahane, Takemi, et al.
Publicado: (2020) -
The Combination of Albumin–Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child–Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria
por: Takaya, Hiroaki, et al.
Publicado: (2021) -
Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients
por: Kaji, Kosuke, et al.
Publicado: (2020) -
Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis
por: Ozutsumi, Takahiro, et al.
Publicado: (2020)